Back To: Home

January 19-23, 2015
PepTalk - San Diego, CA

February 7-11, 2015
SLAS2015 - Washington, DC

More Events

Covance, BioPontis announce drug development agreement
March 2012

PRINCETON, N.J.A three-year, exclusive integrated drug development agreement was recently announced between Covance Inc. and BioPontis Alliance to manage early development of scientific discoveries from academia. Under the agreement, Covance will serve as BioPontis Alliance's exclusive provider of drug development services, including preclinical, bioanalytical, discovery support, CMC, clinical, central labs and commercialization. BioPontis Alliance works to develop early-stage discoveries and technologies, and under the new arrangement, Covance will manage the necessary services for moving compounds from lead optimization to the clinic.  
"Together, with our university and industry partners, we have established a new development model to fuel biopharma's early-stage pipeline and accelerate the availability of new medicines," Richard Basile, CEO and principal of BioPontis Alliance, said in a press release.


Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2014 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.